Literature DB >> 35715619

The effect of gestational diabetes on the fracture risk after pregnancy: a nationwide register-based study.

Matias Vaajala1, Rasmus Liukkonen2, Ilari Kuitunen3,4, Ville Ponkilainen5, Ville M Mattila2,6.   

Abstract

Entities:  

Keywords:  Diabetes; Fracture risk; GDM; Gestational diabetes

Mesh:

Year:  2022        PMID: 35715619      PMCID: PMC9402514          DOI: 10.1007/s00592-022-01907-x

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.087


× No keyword cloud information.

Introduction

Diabetes mellitus (DM) has been reported to increase the risk of fractures due to pathophysiological changes in the bone endocrinology, as well as disorders in glucose metabolism [1]. The prevalence of DM has continued to increase [2], and subsequently it increases the comorbidity burden higher. In addition to the increasing prevalence of DM, the rates of gestational diabetes mellitus (GDM) have been increasing during previous decade [3]. Furthermore, as women whose pregnancies are complicated with GDM are in increased risk of developing the type 2 DM [4], it might also increase the risk of fractures amongst these patients. A previous study from United Kingdom reported, that GDM increases the risk of fractures, especially hip fractures [5]. To the best of our knowledge, no other study has examined the risk of fractures after GDM. Therefore, the aim of this study was to examine, if the GDM increases the risk of fractures in fertile-aged women using nationwide registers.

Materials and methods

In this retrospective register-based study, data from the National Medical Birth Register (MBR) (1.1.2004–31.12.2013) was combined with data from the Care Register for Health Care (1.1.2004–31.12.2018). Both registers are maintained by the Finnish Institute for Health and Welfare. The MBR contains information on pregnancies, delivery statistics, and the perinatal outcomes, including GDM. We included all pregnancies in women aged 15 to 44 recorded in the MBR between 2004 and 2013 that led to birth. In Finland, GDM is diagnosed in second trimester with 75 g oral glucose test. Data from the Care Register for Health Care contained information on all fractures treated at secondary or tertiary level units between 2004 and 2018. International Classification of Diseases tenth revision (ICD-10) codes were used to identify fracture patients. Fractures of the upper extremity, spine and pelvis, and lower extremity were included in the study. The specific ICD-10 codes with definitions for each fracture included in this study are presented in Appendix 1. The dates of the fracture hospitalization periods found in the Care Register for Health Care were used to compare the risk for a woman sustaining a fracture after giving birth. Based on ICD-10 diagnoses, women with diagnosed type 1 DM were excluded. Forming of the study groups is shown in a flowchart in Appendix 2. The Cox regression model was used to evaluate the risk for fracture in women with gestational diabetes. Women without gestational diabetes formed the control group. The start point for the follow-up was the date of giving birth. The endpoint of the follow-up was the first fracture hospitalization after giving birth, start of the next pregnancy, or the common endpoint of the follow-up, which was 1–5 years after giving birth, based on the chosen length of the follow-up. The model was created separately with one, two-, three-, four-, and five-year follow-up (each follow-up time starting from the delivery) to analyze the risk with different time periods after the pregnancy, as the length of the changes in physiology after GDM remains unknown. The models with different follow-up times were analyzed separately. The results were interpreted with hazard ratios (HR) and adjusted hazard ratios (aHR) with 95% confidence intervals (CI). Proportional hazards assumption in the cox model was tested using Schoenfeld residuals, and the assumption was not violated. Models were adjusted with body mass index (BMI), age and smoking status of the mother during pregnancy. The adjustments were chosen based on known risk factors for fractures.

Results

A total of 106 146 pregnancies with GDM were included. Of these, 918 (0.86%) women sustained a fracture during the following 5 years after the pregnancy. The control group consisted of 693 338 pregnancies, of which 5494 (0.57%) women sustained a fracture during the following 5 years. Both study groups had similar absolute risk for the fractures after pregnancy throughout the whole 5-year follow-up, the risk increasing up to 0.012 in both groups (Fig. 1).
Fig. 1

Kaplan–Meier survival curves (with 95% confidence intervals) of women suffering a fracture after giving birth during the following 5-years. Women with gestational diabetes were compared to those without (control group)

Kaplan–Meier survival curves (with 95% confidence intervals) of women suffering a fracture after giving birth during the following 5-years. Women with gestational diabetes were compared to those without (control group) There was no increased risk for any type of fractures observed among women with GDM. In fact, as the follow-up time lengthened, the risk for fractures was lower among women with GDM. With a 4-year follow-up, the aHR for any fracture for women with GDM was 0.89 (CI 0.82–0.96) and with 5-year follow-up 0.90 (CI 0.83–0.97). Adjusting the models decreased the risk for fractures among women with GMD markedly (Table 1).
Table 1

Hazard ratios (HR) and adjusted hazard ratios (aHR) for the event of woman sustaining a fracture of different anatomic regions after giving birth during the follow-up of 1–5 years (each follow-up starting from the delivery). Women with gestational diabetes were compared to those women without. Models were adjusted with smoking status, BMI, and the age of the mother during pregnancy

Follow-up time1-year2-year3-year4-year5-year
Total risk for fractures
HR (CI)0.97 (0.84–1.12)1.02 (0.92–1.13)1.05 (0.97–1.15)1.01 (0.94–1.09)1.01 (0.95–1.09)
aHR (CI)0.87 (0.75–1.01)0.89 (0.80–0.99)0.92 (0.84–1.01)0.89 (0.82–0.96)0.90 (0.83–0.97)
Risk for upper extremity fractures
HR (CI)0.99 (0.81–1.22)0.98 (0.85–1.14)1.01 (0.89–1.15)0.95 (0.85–1.07)0.94 (0.85–1.04)
aHR (CI)0.95 (0.77–1.17)0.92 (0.79–1.08)0.96 (0.84–1.09)0.90 (0.79–1.01)0.89 (0.80–0.99)
Risk for fractures of spine or pelvis
HR (CI)0.72 (0.43–1.21)0.79 (0.54–1.16)0.75 (0.54–1.04)0.70 (0.52–0.95)0.70 (0.53–0.93)
aHR (CI)0.86 (0.50–1.48)0.82 (0.55–1.22)0.77 (0.55–1.08)0.73 (0.53–0.99)0.74 (0.55–0.98)
Risk for lower extremity fractures
HR (CI)1.03 (0.82–1.30)1.22 (1.04–1.44)1.27 (1.11–1.45)1.26 (1.11–1.41)1.28 (1.15–1.43)
aHR (CI)0.78 (0.61–1.00)0.90 (0.76–1.07)0.94 (0.81–1.08)0.93 (0.82–1.06)0.98 (0.87–1.09)
Hazard ratios (HR) and adjusted hazard ratios (aHR) for the event of woman sustaining a fracture of different anatomic regions after giving birth during the follow-up of 1–5 years (each follow-up starting from the delivery). Women with gestational diabetes were compared to those women without. Models were adjusted with smoking status, BMI, and the age of the mother during pregnancy

Discussion

GDM doesn’t increase the risk for fractures after pregnancy based on our results. One study has previously examined the effects of GDM on subsequent fracture risk. In this study, the risk for all fractures and hip fractures was found to be markedly higher [5]. However, based on our results, the toal risk for any fracture after pregnancy was not higher at any case. In addition, the risk for hip fractures was not higher either. According to our results, adjusting the model with BMI, smoking status, and age of the mother decreased the risk for fractures (especially in lower extremity), which might indicate that these factors are more likely the reason for the increase in the risk for fractures, not the physiologic chances caused by GDM. The strength of our study is the large nationwide register with a GDM registered for all pregnancies during the study period. Furthermore, GDM screening practice has remained unchanged during our study period. The register data used in our study are routinely collected with structured forms with national instructions, which ensures good coverage (over 99%) and reduces possible reporting and selection bias. The main limitation of our study is the missing clinical information on the fractures included in this study (e.g., radiological finding, trauma mechanisms).
Table 2

ICD-10 codes with definitions for each fracture included in this study

Fractures of upper extremity ICD-10 codeDefinition
S42.0Fracture of clavicle
S42.1Fracture of scapula
S42.2Fracture of upper end of humerus
S42.3Fracture of shaft of humerus
S42.4Fracture of lower end of humerus
S42.9Fracture of shoulder girdle, part unspecified
S52.0Fracture of upper end of ulna
S52.1Fracture of upper end of radius
S52.2Fracture of shaft of ulna
S52.3Fracture of shaft of radius
S52.5Fracture of lower end of radius
S52.6Fracture of lower end of ulna
S52.9Unspecified fracture of forearm
S62.0Fracture of navicular bone of wrist
S62.1Fracture of other and unspecified carpal bone
  5 in total

1.  Long-term effects of gestational diabetes on bone mineral density and fracture risk: Analysis of the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk) population-based study.

Authors:  Annes Ahmeidat; Sohinee Bhattacharya; Robert N Luben; Kay-Tee Khaw; Phyo K Myint
Journal:  Maturitas       Date:  2020-11-18       Impact factor: 4.342

2.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

3.  Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019.

Authors:  Nilay S Shah; Michael C Wang; Priya M Freaney; Amanda M Perak; Mercedes R Carnethon; Namratha R Kandula; Erica P Gunderson; Kai McKeever Bullard; William A Grobman; Matthew J O'Brien; Sadiya S Khan
Journal:  JAMA       Date:  2021-08-17       Impact factor: 157.335

Review 4.  Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective.

Authors:  Yeyi Zhu; Cuilin Zhang
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 5.  Diagnosis and management of bone fragility in diabetes: an emerging challenge.

Authors:  S L Ferrari; B Abrahamsen; N Napoli; K Akesson; M Chandran; R Eastell; G El-Hajj Fuleihan; R Josse; D L Kendler; M Kraenzlin; A Suzuki; D D Pierroz; A V Schwartz; W D Leslie
Journal:  Osteoporos Int       Date:  2018-07-31       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.